{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:50:28Z","timestamp":1791521428310,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.)","award":["01GI0925"],"award-info":[{"award-number":["01GI0925"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00125-017-4385-1","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T20:19:08Z","timestamp":1502223548000},"page":"2240-2251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":141,"title":["Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion"],"prefix":"10.1007","volume":"60","author":[{"given":"Felicia","family":"Gerst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhura","family":"Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Heni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Machann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte N.","family":"Bongers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Sartorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Nadalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"K\u00f6nigsrainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Siegel-Axel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"key":"4385_CR1","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1210\/jc.2009-0584","volume":"94","author":"I Lingvay","year":"2009","unstructured":"Lingvay I, Esser V, Legendre JL et al (2009) Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 94:4070\u20134076","journal-title":"J Clin Endocrinol Metab"},{"key":"4385_CR2","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1007\/s00125-015-3718-1","volume":"58","author":"KG Hollingsworth","year":"2015","unstructured":"Hollingsworth KG, Al Mrabeh A, Steven S, Taylor R (2015) Pancreatic triacylglycerol distribution in type 2 diabetes. Diabetologia 58:2676\u20132678","journal-title":"Diabetologia"},{"key":"4385_CR3","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2337\/dc16-0074","volume":"39","author":"H Yamazaki","year":"2016","unstructured":"Yamazaki H, Tsuboya T, Katanuma A et al (2016) Lack of independent association between fatty pancreas and incidence of type 2 diabetes mellitus: 5-year Japanese cohort study. Diabetes Care 39:1677\u20131683","journal-title":"Diabetes Care"},{"key":"4385_CR4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/dmrr.1073","volume":"26","author":"M Heni","year":"2010","unstructured":"Heni M, Machann J, Staiger H et al (2010) Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and\/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 26:200\u2013205","journal-title":"Diabetes Metab Res Rev"},{"key":"4385_CR5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/oby.2007.110","volume":"16","author":"KE Pinnick","year":"2008","unstructured":"Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA (2008) Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity 16:522\u2013530","journal-title":"Obesity"},{"key":"4385_CR6","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.2337\/dc07-0326","volume":"30","author":"ME Tushuizen","year":"2007","unstructured":"Tushuizen ME, Bunck MC, Pouwels PJ et al (2007) Pancreatic fat content and \u03b2-cell function in men with and without type 2 diabetes. Diabetes Care 30:2916\u20132921","journal-title":"Diabetes Care"},{"key":"4385_CR7","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2337\/dc12-0701","volume":"35","author":"LS Szczepaniak","year":"2012","unstructured":"Szczepaniak LS, Victor RG, Mathur R et al (2012) Pancreatic steatosis and its relationship to beta-cell dysfunction in humans: racial and ethnic variations. Diabetes Care 35:2377\u20132383","journal-title":"Diabetes Care"},{"key":"4385_CR8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s00125-015-3544-5","volume":"8","author":"P Begovatz","year":"2015","unstructured":"Begovatz P, Koliaki C, Weber K et al (2015) Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans. Diabetologia 8:1646\u20131655","journal-title":"Diabetologia"},{"key":"4385_CR9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","volume":"9","author":"N Stefan","year":"2013","unstructured":"Stefan N, H\u00e4ring HU (2013) The role of hepatokines in metabolism. Nat Rev Endocrinol 9:144\u2013152","journal-title":"Nat Rev Endocrinol"},{"key":"4385_CR10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98\u2013107","journal-title":"Nat Rev Immunol"},{"key":"4385_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbalip.2009.08.006","volume":"1801","author":"V Poitout","year":"2010","unstructured":"Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontes G (2010) Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 1801:289\u2013298","journal-title":"Biochim Biophys Acta"},{"key":"4385_CR12","first-page":"1445","volume":"7","author":"PR Srinivas","year":"1993","unstructured":"Srinivas PR, Wagner AS, Reddy LV et al (1993) Serum \u03b12-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 7:1445\u20131455","journal-title":"Mol Endocrinol"},{"key":"4385_CR13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0303-7207(00)00237-9","volume":"164","author":"ST Mathews","year":"2000","unstructured":"Mathews ST, Chellam N, Srinivas PR et al (2000) \u03b12-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 164:87\u201398","journal-title":"Mol Cell Endocrinol"},{"key":"4385_CR14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cellsig.2010.11.003","volume":"23","author":"AS Goustin","year":"2011","unstructured":"Goustin AS, Abou-Samra AB (2011) The \u201cthrifty\u201d gene encoding AHSG\/fetuin-A meets the insulin receptor: insights into the mechanism of insulin resistance. Cell Signal 23:980\u2013990","journal-title":"Cell Signal"},{"key":"4385_CR15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068\u20131083","journal-title":"Lancet"},{"key":"4385_CR16","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s00125-012-2466-8","volume":"55","author":"JJ Meier","year":"2012","unstructured":"Meier JJ, Breuer TG, Bonadonna RC et al (2012) Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia 55:1346\u20131354","journal-title":"Diabetologia"},{"key":"4385_CR17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","volume":"150","author":"C Talchai","year":"2012","unstructured":"Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150:1223\u20131234","journal-title":"Cell"},{"key":"4385_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2013.12.002","volume":"19","author":"T Gao","year":"2014","unstructured":"Gao T, McKenna B, Li C et al (2014) Pdx1 maintains beta cell identity and function by repressing an alpha cell program. Cell Metab 19:259\u2013271","journal-title":"Cell Metab"},{"key":"4385_CR19","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI29103","volume":"116","author":"M Prentki","year":"2006","unstructured":"Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802\u20131812","journal-title":"J Clin Invest"},{"key":"4385_CR20","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00125-010-1707-y","volume":"53","author":"M Igoillo-Esteve","year":"2010","unstructured":"Igoillo-Esteve M, Marselli L, Cunha DA et al (2010) Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 53:1395\u20131405","journal-title":"Diabetologia"},{"key":"4385_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/db09-0512","volume":"59","author":"AM Hennige","year":"2010","unstructured":"Hennige AM, Ranta F, Heinzelmann I et al (2010) Overexpression of kinase-negative protein kinase C\u03b4 in pancreatic \u03b2-cells protects mice from diet-induced glucose intolerance and \u03b2-cell dysfunction. Diabetes 59:119\u2013127","journal-title":"Diabetes"},{"key":"4385_CR22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cmet.2012.01.023","volume":"15","author":"K Eguchi","year":"2012","unstructured":"Eguchi K, Manabe I, Oishi-Tanaka Y et al (2012) Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation. Cell Metab 15:518\u2013533","journal-title":"Cell Metab"},{"key":"4385_CR23","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00125-014-3249-1","volume":"57","author":"D Nackiewicz","year":"2014","unstructured":"Nackiewicz D, Dan M, He W et al (2014) TLR2\/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6. Diabetologia 57:1645\u20131654","journal-title":"Diabetologia"},{"key":"4385_CR24","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2337\/db06-1650","volume":"56","author":"JA Ehses","year":"2007","unstructured":"Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356\u20132370","journal-title":"Diabetes"},{"key":"4385_CR25","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s00125-009-1410-z","volume":"52","author":"SJ Richardson","year":"2009","unstructured":"Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) Islet-associated macrophages in type 2 diabetes. Diabetologia 52:1686\u20131688","journal-title":"Diabetologia"},{"key":"4385_CR26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","volume":"29","author":"N Stefan","year":"2006","unstructured":"Stefan N, Hennige AM, Staiger H et al (2006) \u03b12-Heremans\u2013Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29:853\u2013857","journal-title":"Diabetes Care"},{"key":"4385_CR27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nm.3116","volume":"19","author":"N Stefan","year":"2013","unstructured":"Stefan N, H\u00e4ring HU (2013) Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med 19:394\u2013395","journal-title":"Nat Med"},{"key":"4385_CR28","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1016\/S0021-9258(19)39445-1","volume":"265","author":"AJ Cayatte","year":"1990","unstructured":"Cayatte AJ, Kumbla L, Subbiah MT (1990) Marked acceleration of exogenous fatty acid incorporation into cellular triglycerides by fetuin. J Biol Chem 265:5883\u20135888","journal-title":"J Biol Chem"},{"key":"4385_CR29","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","volume":"18","author":"D Pal","year":"2012","unstructured":"Pal D, DasGupta S, Kundu R et al (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18:1279\u20131285","journal-title":"Nat Med"},{"key":"4385_CR30","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00125-014-3177-0","volume":"57","author":"DI Siegel-Axel","year":"2014","unstructured":"Siegel-Axel DI, Ullrich S, Stefan N et al (2014) Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells. Diabetologia 57:1057\u20131066","journal-title":"Diabetologia"},{"key":"4385_CR31","doi-asserted-by":"crossref","first-page":"28324","DOI":"10.1074\/jbc.C113.495473","volume":"288","author":"P Chatterjee","year":"2013","unstructured":"Chatterjee P, Seal S, Mukherjee S et al (2013) Adipocyte fetuin-A contributes to macrophage migration into adipose tissue and polarization of macrophages. J Biol Chem 288:28324\u201328330","journal-title":"J Biol Chem"},{"key":"4385_CR32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00223-012-9690-6","volume":"93","author":"L Brylka","year":"2013","unstructured":"Brylka L, Jahnen-Dechent W (2013) The role of fetuin-A in physiological and pathological mineralization. Calcif Tissue Int 93:355\u2013364","journal-title":"Calcif Tissue Int"},{"key":"4385_CR33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00024382-200115030-00004","volume":"15","author":"M Ombrellino","year":"2001","unstructured":"Ombrellino M, Wang H, Yang H et al (2001) Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 15:181\u2013185","journal-title":"Shock"},{"key":"4385_CR34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/156652412800620039","volume":"12","author":"H Wang","year":"2012","unstructured":"Wang H, Sama AE (2012) Anti-inflammatory role of fetuin-A in injury and infection. Curr Mol Med 12:625\u2013633","journal-title":"Curr Mol Med"},{"key":"4385_CR35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S2213-8587(13)70170-0","volume":"2","author":"N Stefan","year":"2014","unstructured":"Stefan N, Ramsauer M, Jordan P et al (2014) Inhibition of 11\u03b2-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2:406\u2013416","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4385_CR36","doi-asserted-by":"crossref","first-page":"e92238","DOI":"10.1371\/journal.pone.0092238","volume":"9","author":"N Stefan","year":"2014","unstructured":"Stefan N, Sun Q, Fritsche A et al (2014) Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies. PLoS One 9:e92238","journal-title":"PLoS One"},{"key":"4385_CR37","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/db09-1177","volume":"59","author":"D Bosco","year":"2010","unstructured":"Bosco D, Armanet M, Morel P et al (2010) Unique arrangement of \u03b1- and \u03b2-cells in human islets of Langerhans. Diabetes 59:1202\u20131210","journal-title":"Diabetes"},{"key":"4385_CR38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1677\/JOE-08-0131","volume":"198","author":"HE Kim","year":"2008","unstructured":"Kim HE, Choi SE, Lee SJ et al (2008) Tumour necrosis factor-\u03b1-induced glucose-stimulated insulin secretion inhibition in INS-1 cells is ascribed to a reduction of the glucose-stimulated Ca2+ influx. J Endocrinol 198:549\u2013560","journal-title":"J Endocrinol"},{"key":"4385_CR39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cmet.2014.05.005","volume":"20","author":"AI Wernstedt","year":"2014","unstructured":"Wernstedt AI, Tao C, Morley TS et al (2014) Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab 20:103\u2013118","journal-title":"Cell Metab"},{"key":"4385_CR40","doi-asserted-by":"crossref","first-page":"28430","DOI":"10.1074\/jbc.M103382200","volume":"276","author":"DJ Klemm","year":"2001","unstructured":"Klemm DJ, Leitner JW, Watson P et al (2001) Insulin-induced adipocyte differentiation. Activation of CREB rescues adipogenesis from the arrest caused by inhibition of prenylation. J Biol Chem 276:28430\u201328435","journal-title":"J Biol Chem"},{"key":"4385_CR41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","volume":"110","author":"K Maedler","year":"2002","unstructured":"Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced beta cell production of IL-1\u03b2 contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851\u2013860","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"4385_CR42","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.2337\/diabetes.54.suppl_2.S108","volume":"54","author":"MY Donath","year":"2005","unstructured":"Donath MY, Ehses JA, Maedler K et al (2005) Mechanisms of \u03b2-cell death in type 2 diabetes. Diabetes 54(Suppl 2):S108\u2013S113","journal-title":"Diabetes"},{"key":"4385_CR43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1042\/BST0360340","volume":"36","author":"JA Ehses","year":"2008","unstructured":"Ehses JA, Boni-Schnetzler M, Faulenbach M, Donath MY (2008) Macrophages, cytokines and \u03b2-cell death in type 2 diabetes. Biochem Soc Trans 36:340\u2013342","journal-title":"Biochem Soc Trans"},{"issue":"Suppl 2","key":"4385_CR44","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.2337\/dcS13-2008","volume":"36","author":"JJ Meier","year":"2013","unstructured":"Meier JJ, Bonadonna RC (2013) Role of reduced \u03b2-cell mass versus impaired \u03b2-cell function in the pathogenesis of type 2 diabetes. Diabetes Care 36(Suppl 2):S113\u2013S119","journal-title":"Diabetes Care"},{"key":"4385_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2015.05.014","volume":"412","author":"X Shen","year":"2015","unstructured":"Shen X, Yang L, Yan S et al (2015) Fetuin A promotes lipotoxicity in beta cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity. Mol Cell Endocrinol 412:1\u201311","journal-title":"Mol Cell Endocrinol"},{"key":"4385_CR46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0165-2478(97)00126-0","volume":"60","author":"KM Dziegielewska","year":"1998","unstructured":"Dziegielewska KM, Andersen NA, Saunders NR (1998) Modification of macrophage response to lipopolysaccharide by fetuin. Immunol Lett 60:31\u201335","journal-title":"Immunol Lett"},{"key":"4385_CR47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/JOE-12-0223","volume":"214","author":"KM Silva da","year":"2012","unstructured":"da Silva KM, Bittencourt A, de Bittencourt PIH et al (2012) Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic \u03b2-cell line and mouse islets. J Endocrinol 214:301\u2013311","journal-title":"J Endocrinol"},{"key":"4385_CR48","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.2337\/db12-1097","volume":"62","author":"J Lanuza-Masdeu","year":"2013","unstructured":"Lanuza-Masdeu J, Arevalo MI, Vila C, Barbera A, Gomis R, Caelles C (2013) In vivo JNK activation in pancreatic \u03b2-cells leads to glucose intolerance caused by insulin resistance in pancreas. Diabetes 62:2308\u20132317","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"4385_CR49","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.2337\/diabetes.51.2007.S212","volume":"51","author":"RN Bergman","year":"2002","unstructured":"Bergman RN, Ader M, Huecking K, van Citters G (2002) Accurate assessment of \u03b2-cell function: the hyperbolic correction. Diabetes 51(Suppl 1):S212\u2013S220","journal-title":"Diabetes"},{"key":"4385_CR50","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1055\/s-2007-996292","volume":"12","author":"S Kawazu","year":"1980","unstructured":"Kawazu S, Kanazawa Y, Hayashi M, Ikeuchi M, Nakai T, Kosaka K (1980) Monolayer culture of human fetal and adult pancreas. Static and dynamic studies of insulin release in vitro. Horm Metab Res 12:354\u2013360","journal-title":"Horm Metab Res"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4385-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T22:09:44Z","timestamp":1659305384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,8]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["4385"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4385-1","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,8]]}}}